医薬品開発業務アウトソーシング(CRO)の世界市場分析・規模・シェア・成長・動向・予測:サービス別(臨床試験サービス、薬事サービス、臨床データ管理・バイオメトリクス、メディカルライティング、医薬品安全性監視、サイト管理プロトコル、その他)、治療分野別(腫瘍・血液科、中枢神経系、心血管/代謝、呼吸器、感染病、免疫学、希少疾患、医療機器)

【英語タイトル】Healthcare Contract Research Outsourcing Market - (Service – Clinical Trial Services (preclinical and Clinical), Regulatory Services, Clinical Data Management and Biometrics (Electronica Data Management, Electronic Patient Report Outcomes), Medical Writing, Pharmacovigilance, Site Management Protocol; Therapeutic area – Oncology/Hematology, CNS, CV/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices; End Use – Pharmaceutical Companies, Biotechnology Companies, Medical Devices, Academic Institutes and Government Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Transparency Market Researchが出版した調査資料(TMR8100919)・商品コード:TMR8100919
・発行会社(調査会社):Transparency Market Research
・発行日:2018年3月
・ページ数:200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル、世界主要地域・国
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,795 ⇒換算¥631,655見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,795 ⇒換算¥958,655見積依頼/購入/質問フォーム
Global Site LicenseUSD11,795 ⇒換算¥1,285,655見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Transparency Market Researchの本調査レポートは、医薬品開発業務アウトソーシング(CRO)の世界市場について調べ、医薬品開発業務アウトソーシング(CRO)の世界規模、市場動向、市場環境、サービス別(臨床試験サービス、薬事サービス、臨床データ管理・バイオメトリクス、メディカルライティング、医薬品安全性監視、サイト管理プロトコル、その他)分析、治療分野別(腫瘍・血液科、中枢神経系、心血管/代謝、呼吸器、感染病、免疫学、希少疾患、医療機器)
分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。

・序文・調査範囲・調査手法
・エグゼクティブサマリー
・医薬品開発業務アウトソーシング(CRO)の世界市場動向
・医薬品開発業務アウトソーシング(CRO)の世界市場環境
・医薬品開発業務アウトソーシング(CRO)の世界市場規模
・医薬品開発業務アウトソーシング(CRO)の世界市場規模:サービス別(臨床試験サービス、薬事サービス、臨床データ管理・バイオメトリクス、メディカルライティング、医薬品安全性監視、サイト管理プロトコル、その他)
・医薬品開発業務アウトソーシング(CRO)の世界市場規模:治療分野別(腫瘍・血液科、中枢神経系、心血管/代謝、呼吸器、感染病、免疫学、希少疾患、医療機器)

・医薬品開発業務アウトソーシング(CRO)の世界市場:地域別市場規模・分析
・医薬品開発業務アウトソーシング(CRO)の北米市場規模・予測
・医薬品開発業務アウトソーシング(CRO)のアメリカ市場規模・予測
・医薬品開発業務アウトソーシング(CRO)のヨーロッパ市場規模・予測
・医薬品開発業務アウトソーシング(CRO)のアジア市場規模・予測
・医薬品開発業務アウトソーシング(CRO)の日本市場規模・予測
・医薬品開発業務アウトソーシング(CRO)の中国市場規模・予測
・医薬品開発業務アウトソーシング(CRO)のインド市場規模・予測
・競争状況・関連企業情報
【レポートの概要】

Global Healthcare Contract Research Outsourcing Market: Overview

Now-a-days the drug development process is characterized by large clinical trials, rapid changes in trials protocols for efficient management of data generated and complex procedures, with the growing price of in-house research, the demand for contract research outsourcing is also increasing. These trends have formed pressure on healthcare companies to develop efficient drug development and product commercialization process. Along with the drug development efficiency, healthcare companies are looking to merge and simplify the supply chain, directing sourcing among a preferred number of multiple service providers. In response, large CROs are actively expanding their offerings beyond core clinical research services. Contract research organizations work closely with healthcare companies to conduct clinical research programs and support marketing activities for them. An increasing number of healthcare companies are outsourcing their clinical trials and other services to the contract research organizations.

This report on the healthcare contract research outsourcing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year.

Market related factors such as technological developments, product innovation, services offered, infrastructure facilities around the world, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the healthcare contract research outsourcing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Global Healthcare Contract Research Outsourcing Market: Key Segments

On the basis of services, the healthcare contract research outsourcing market is categorized into clinical trial services, regulatory services, clinical data management & biometrics, medical writing, pharmacovigilance, site management protocol and others. On the basis of therapeutic area the healthcare contract research outsourcing market is categorized into oncology/hematology, CNS, CV/metabolic, respiratory, infectious diseases, immunology, rare diseases, medical devices and others. In terms of end users, the healthcare contract research outsourcing market is segmented into hospitals, home care and clinics.

On the basis of geography, the healthcare contract research outsourcing market is segmented into North America, Europe, Asia Pacific and Rest of the world. North America comprises the U.S. and Canada. Europe comprises Germany, France, U.K., Spain, Italy and Rest of Europe. Asia-Pacific comprises China, India, Japan, Australia and New Zealand and Rest of Asia Pacific. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the healthcare contract research outsourcing market.

Companies Mentioned in Report

The report also profiles major players in the healthcare contract research outsourcing market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Syneos Health, PAREXEL International, ICON PLC, PRA Health Sciences, Inc., Charles River, Laboratory Corporation of America Holdings (Covance), IQVIA, Medpace, Pharmaceutical Product Development, LLC.

The Global Healthcare Contract Research Outsourcing market has been segmented as follows:

Global Healthcare Contract Research Outsourcings Market, by Service
Clinical Trial Service
Preclinical
Clinical
Regulatory Service
Clinical Data Management & Biometrics
Electronic data capture
Electronic Patient Recorded Outcomes
Others
Medical Writing
Pharmacovigilance
Site Management Protocol
Others

Global Healthcare Contract Research Outsourcings Market, by Therapeutic Area
Oncology/Hematology
CNS
CV/Metabolic
Respiratory
Infectious Diseases
Immunology
Rare Diseases
Medical Devices
Others

Global Healthcare Contract Research Outsourcings Market, by End User
Pharmaceutical Companies
Biotechnology Companies
Medical Device Companies
Academic Institutes & Government organizations

Global Healthcare Contract Research Outsourcings Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
Japan
China
India
Australia & New Zealand
Rest of Asia Pacific
Rest of the World

【レポートの目次】

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Healthcare Contract Research Outsourcings Market

4. Market Overview
4.1. Introduction
4.1.1. Service Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, 2015–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Porter’s Five Force Analysis
4.7. Regulatory Scenario
4.7.1. North America
4.7.2. Europe
4.7.3. Asia Pacific
4.8. Key Mergers and Acquisitions
4.9. Time and Cost Reduction in Clinical Trials
4.10. Market Outlook

5. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, By Service
5.1. Introduction & Definition
5.2. Key Findings
5.4. Market Value Forecast By Service , 2015–2025
5.4.1. Clinical Trial Service
5.4.1.1. Preclinical
5.4.1.2. Clinical
5.4.2. Regulatory Service
5.4.3. Clinical Data Management & Biometrics
5.4.3.1. Electronic data capture
5.4.3.2. Electronic Patient Recorded Outcomes
5.4.3.3. Others
5.4.4. Medical Writing
5.4.5. Pharmacovigilance
5.4.6. Site Management Protocol
5.4.7. Others
5.5. Market Attractiveness By Service

6. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, By Therapeutic Area
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.4. Market Value Forecast By Therapeutic Area , 2015–2025
6.4.1. Oncology/Hematology
6.4.2. CNS
6.4.3. CV/Metabolic
6.4.4. Respiratory
6.4.5. Infectious Diseases
6.4.6. Immunology
6.4.7. Rare Diseases
6.4.8. Medical Devices
6.4.9. Others
6.5. Market Attractiveness By Therapeutic Area

7. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, By End User
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.4. Market Value Forecast By End User, 2015–2025
7.4.1. Pharmaceutical Companies
7.4.2. Biotechnology Companies
7.4.3. Medical Device Companies
7.4.4. Academic Institutes & Government organizations
7.5. Market Attractiveness By End User

8. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Rest of the World
8.4. Market Attractiveness By Country/Region

9. North America Healthcare Contract Research Outsourcings Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Service , 2015–2025
9.2.1. Clinical Trial Service
9.2.1.1. Preclinical
9.2.1.2. Clinical
9.2.2. Regulatory Service
9.2.3. Clinical Data Management & Biometrics
9.2.3.1. Electronic data capture
9.2.3.2. Electronic Patient Recorded Outcomes
9.2.3.3. Others
9.2.4. Medical Writing
9.2.5. Pharmacovigilance
9.2.6. Site Management Protocol
9.2.7. Others
9.3. Market Value Forecast By Therapeutic Area , 2015–2025
9.3.1. Oncology/Hematology
9.3.2. CNS
9.3.3. CV/Metabolic
9.3.4. Respiratory
9.3.5. Infectious Diseases
9.3.6. Immunology
9.3.7. Rare Diseases
9.3.8. Medical Devices
9.3.9. Others
9.4. Market Value Forecast By End User, 2015–2025
9.4.1. Pharmaceutical Companies
9.4.2. Biotechnology Companies
9.4.3. Medical Device Companies
9.4.4. Academic Institutes & Government organizations
9.5. Market Value Forecast By Country , 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Service
9.6.2. By Therapeutic Area
9.6.3. By End User
9.6.4. By Country

10. Europe Healthcare Contract Research Outsourcings Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Service , 2015–2025
10.2.1. Clinical Trial Service
10.2.1.1. Preclinical
10.2.1.2. Clinical
10.2.2. Regulatory Service
10.2.3. Clinical Data Management & Biometrics
10.2.3.1. Electronic data capture
10.2.3.2. Electronic Patient Recorded Outcomes
10.2.3.3. Others
10.2.4. Medical Writing
10.2.5. Pharmacovigilance
10.2.6. Site Management Protocol
10.2.7. Others
10.3. Market Value Forecast By Therapeutic Area , 2015–2025
10.3.1. Oncology/Hematology
10.3.2. CNS
10.3.3. CV/Metabolic
10.3.4. Respiratory
10.3.5. Infectious Diseases
10.3.6. Immunology
10.3.7. Rare Diseases
10.3.8. Medical Devices
10.3.9. Others
10.4. Market Value Forecast By End User, 2015–2025
10.4.1. Pharmaceutical Companies
10.4.2. Biotechnology Companies
10.4.3. Medical Device Companies
10.4.4. Academic Institutes & Government organizations
10.5. Market Value Forecast By Country , 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Service
10.6.2. By Therapeutic Area
10.6.3. By End User
10.6.4. By Country

11. Asia Pacific Healthcare Contract Research Outsourcings Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Service , 2015–2025
11.2.1. Clinical Trial Service
11.2.1.1. Preclinical
11.2.1.2. Clinical
11.2.2. Regulatory Service
11.2.3. Clinical Data Management & Biometrics
11.2.3.1. Electronic data capture
11.2.3.2. Electronic Patient Recorded Outcomes
11.2.3.3. Others
11.2.4. Medical Writing
11.2.5. Pharmacovigilance
11.2.6. Site Management Protocol
11.2.7. Others
11.3. Market Value Forecast By Therapeutic Area , 2015–2025
11.3.1. Oncology/Hematology
11.3.2. CNS
11.3.3. CV/Metabolic
11.3.4. Respiratory
11.3.5. Infectious Diseases
11.3.6. Immunology
11.3.7. Rare Diseases
11.3.8. Medical Devices
11.3.9. Others
11.4. Market Value Forecast By End User, 2015–2025
11.4.1. Pharmaceutical Companies
11.4.2. Biotechnology Companies
11.4.3. Medical Device Companies
11.4.4. Academic Institutes & Government organizations
11.5. Market Value Forecast By Country , 2015–2025
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Service
11.6.2. By Therapeutic Area
11.6.3. By End User
11.6.4. By Country

12. Rest of the World Healthcare Contract Research Outsourcings Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Service , 2015–2025
12.2.1. Clinical Trial Service
12.2.1.1. Preclinical
12.2.1.2. Clinical
12.2.2. Regulatory Service
12.2.3. Clinical Data Management & Biometrics
12.2.3.1. Electronic data capture
12.2.3.2. Electronic Patient Recorded Outcomes
12.2.3.3. Others
12.2.4. Medical Writing
12.2.5. Pharmacovigilance
12.2.6. Site Management Protocol
12.2.7. Others
12.3. Market Value Forecast By Therapeutic Area , 2015–2025
12.3.1. Oncology/Hematology
12.3.2. CNS
12.3.3. CV/Metabolic
12.3.4. Respiratory
12.3.5. Infectious Diseases
12.3.6. Immunology
12.3.7. Rare Diseases
12.3.8. Medical Devices
12.3.9. Others
12.4. Market Value Forecast By End User, 2015–2025
12.4.1. Pharmaceutical Companies
12.4.2. Biotechnology Companies
12.4.3. Medical Device Companies
12.4.4. Academic Institutes & Government organizations
12.5. Market Value Forecast By Country , 2015–2025
12.6. Market Attractiveness Analysis
12.6.1. By Service
12.6.2. By Therapeutic Area
12.6.3. By End User
12.6.4. By Country

13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Market Share Analysis By Company (2016)
13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.3.1. Syneos Health
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. SWOT Analysis
13.3.1.5. Strategic Overview
13.3.2. PAREXEL International
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Overview
13.3.2.3. Product Portfolio
13.3.2.4. SWOT Analysis
13.3.2.5. Strategic Overview
13.3.3. ICON PLC
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Financial Overview
13.3.3.3. Product Portfolio
13.3.3.4. SWOT Analysis
13.3.3.5. Strategic Overview
13.3.4. PRA Health Sciences, Inc.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Financial Overview
13.3.4.3. Product Portfolio
13.3.4.4. SWOT Analysis
13.3.4.5. Strategic Overview
13.3.5. Charles River
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Overview
13.3.5.3. Product Portfolio
13.3.5.4. SWOT Analysis
13.3.5.5. Strategic Overview
13.3.6. Laboratory Corporation of America Holdings (Covance)
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Overview
13.3.6.3. Product Portfolio
13.3.6.4. SWOT Analysis
13.3.6.5. Strategic Overview
13.3.7. IQVIA
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Overview
13.3.7.3. Product Portfolio
13.3.7.4. SWOT Analysis
13.3.7.5. Strategic Overview
13.3.8. Medpace
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Financial Overview
13.3.8.3. Product Portfolio
13.3.8.4. SWOT Analysis
13.3.8.5. Strategic Overview
13.3.9. Pharmaceutical Product Development, LLC.
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Financial Overview
13.3.9.3. Product Portfolio
13.3.9.4. SWOT Analysis
13.3.9.5. Strategic Overview

List of Tables

Table 01: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2025
Table 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2025
Table 03: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2025
Table 04: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 05: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 06: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 07: North America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 08: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2025
Table 09: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Service, 2017–2025
Table 10: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2025
Table 11: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 12: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 13: Europe Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 14: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Services, 2017–2025
Table 15: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2025
Table 16: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2025
Table 17: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 18: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 19: Asia Pacific Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 20: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2025
Table 21: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2025
Table 22: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2025
Table 23: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 24: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 25: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2025
Table 26: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2025
Table 27: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2025
Table 28: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 29: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025

List of Figures

Figure 01: Healthcare Contract Research Outsourcing Market Snapshot
Figure 02: Revenue Share, 2016
Figure 03: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2015–2025
Figure 05: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area (2016)
Figure 07: Global Healthcare Contract Research Outsourcing Market Value Share, by Region (2016)
Figure 04: Global Healthcare Contract Research Outsourcing Market Value Share, by Service (2016)
Figure 06: Global Healthcare Contract Research Outsourcing Market Value Share, by End-user (2016)
Figure 08: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2017 and 2025
Figure 09: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Trial Services, 2015–2025
Figure 10: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Regulatory Services, 2015–2025
Figure 11: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Data Management & Biometrics, 2015–2025
Figure 12: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Writing, 2015–2025
Figure 13: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmacovigilance, 2015–2025
Figure 14: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Site Management Protocol, 2015–2025
Figure 15: Global Healthcare Contract Research Outsourcing Market Attractiveness, by Service
Figure 16: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2017 and 2025
Figure 17: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Oncology, 2015–2025
Figure 18: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CNS, 2015–2025
Figure 19: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CV/Metabolic, 2015–2025
Figure 20: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Respiratory, 2015–2025
Figure 21: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Infectious Diseases, 2015–2025
Figure 22: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Immunology, 2015–2025
Figure 23: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Rare Diseases, 2015–2025
Figure 24: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Devices, 2015–2025
Figure 25: Global Healthcare Contract Research Outsourcing Market Attractiveness, by Therapeutic Area
Figure 26: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by End-user, 2017 and 2025
Figure 27: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmaceutical Companies, 2015–2025
Figure 28: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Biotechnology Companies, 2015–2025
Figure 29: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Device Companies, 2015–2025
Figure 30: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Academic Institute & Government Organizations Companies, 2015–2025
Figure 31: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2017–2025
Figure 32: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by Region, 2017 and 2025
Figure 33: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Region, 2017–2025
Figure 34: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2015–2025
Figure 35: North America Healthcare Contract Research Outsourcing Market Value Share, by Country, 2017 and 2025
Figure 36: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country
Figure 37: North America Healthcare Contract Research Outsourcing Market Value Share, by Services, 2017 and 2025
Figure 38: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services
Figure 39: North America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area
Figure 40: North America Healthcare Contract Research Outsourcing Market Attractiveness, by Therapeutic Area, 2017–2025
Figure 41: North America Healthcare Contract Research Outsourcing Market Value Share, by End User, 2017 and 2025
Figure 42: North America Healthcare Contract Research Outsourcing Market Attractiveness, by End User, 2017–2025
Figure 43: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2015–2025
Figure 44: Europe Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 45: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 46: Europe Healthcare Contract Research Outsourcing Market Value Share, by Services, 2017 and 2025
Figure 47: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2017–2025
Figure 48: Europe Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2017 and 2025
Figure 49: Europe Healthcare Contract Research Outsourcing Market Attractiveness, by Therapeutic Area, 2017–2025
Figure 50: Europe Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2017 and 2025
Figure 51: Europe Healthcare Contract Research Outsourcing Market Attractiveness, by End-user, 2017–2025
Figure 52: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2025
Figure 53: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 54: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region
Figure 55: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Service, 2017 and 2025
Figure 56: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service
Figure 57: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area
Figure 58: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness, by Therapeutic Area, 2017–2025
Figure 59: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2017 and 2025
Figure 60: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness, by End-user, 2017–2025
Figure 61: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2015–2025
Figure 62: Rest of World Healthcare Contract Research Outsourcing Market Value Share, by Service, 2017 and 2025
Figure 63: Rest of World Healthcare Contract Research Outsourcing Market Attractiveness, by Service
Figure 64: Rest of World Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area 2017 and 2025
Figure 65: Rest of World Healthcare Contract Research Outsourcing Market Attractiveness, by Therapeutic Area, 2017–2025
Figure 66: Rest of World Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2017 and 2025
Figure 67: Rest of World Healthcare Contract Research Outsourcing Market Attractiveness, by End-user, 2017–2025
Figure 68: Global Healthcare Contract Research Outsourcing Market Share Analysis, by Company (2016)
Figure 69: Syneos Health Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 70: PAREXEL International Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2017
Figure 71: ICON PLC Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 72: PRA Health Sciences, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 73: Charles River Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 74: Laboratory Corporation of America Holdings (Covance) Revenue (US$ Mn) & Y-o-Y Growth (%), 2012–2016
Figure 75: IQVIA Revenue (US$ Mn) & Y-o-Y Growth (%), 2012–2016
Figure 76: Medpace Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016

★調査レポート[医薬品開発業務アウトソーシング(CRO)の世界市場分析・規模・シェア・成長・動向・予測:サービス別(臨床試験サービス、薬事サービス、臨床データ管理・バイオメトリクス、メディカルライティング、医薬品安全性監視、サイト管理プロトコル、その他)、治療分野別(腫瘍・血液科、中枢神経系、心血管/代謝、呼吸器、感染病、免疫学、希少疾患、医療機器)] (コード:TMR8100919)販売に関する免責事項を必ずご確認ください。
★調査レポート[医薬品開発業務アウトソーシング(CRO)の世界市場分析・規模・シェア・成長・動向・予測:サービス別(臨床試験サービス、薬事サービス、臨床データ管理・バイオメトリクス、メディカルライティング、医薬品安全性監視、サイト管理プロトコル、その他)、治療分野別(腫瘍・血液科、中枢神経系、心血管/代謝、呼吸器、感染病、免疫学、希少疾患、医療機器)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆